FDA Advisers to Vet J&J's One-Shot Vaccine for Emergency Use

Johnson & Johnson’s coronavirus vaccine is set for vetting by a panel of outside advisers to the U.S. Food and Drug Administration Friday, one of the final steps toward potential authorization of the country’s first one-dose immunization against COVID-19. If the panel votes…